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1. Introduction  
The genetic material, DNA, which encodes genes needed for the production of essential 
proteins, is vulnerable to damage in a number of ways. Human DNA is assaulted on a daily 
basis by a variety of exogenous factors including UV light, cigarette smoke, dietary factors, 
and other carcinogens all of which can cause varying degrees of DNA damage and can lead 
to mutations. Similarly, endogenous factors such as undue DNA replication which can cause 
mismatches, hydrolysis leading to spontaneous DNA depurination, replication form 
collapse which can result in strand breaks, loss of bases because of spontaneous 
disintegration of chemical bonds, and DNA damage secondary to endogenous reactants 
such as alkyl groups, metal cations, and reactive oxygen species (ROS) which can induce 
base oxidation and DNA breaks also contribute to DNA damage (Branzei & Foiani, 2008; 
Capella et al., 2008) 
When DNA is damaged, an intertwined network of surveillance mechanisms will act 
including 
• Sensing and recognizing DNA damage by activation of cell cycle checkpoints, pause 
that permit assessment and complete of DNA processing , either DNA damage repair or 
processing of DNA intermediates 
• Up regulation a large number of genes 
• Programmed cell death or apoptosis when the cell is unable to repair the damage 
sustained and 
• Elicitation of multiple distinct DNA repair responses 
DNA damages are repaired by enzymes coded by one or more DNA repair pathways 
according to their structure, or their location in the cellular genome. DNA repair enzymes 
can be characterized as cellular proteins acting directly on damaged DNA in an attempt to 
restore the correct DNA sequence and structure. These relatively specialized enzymes 
appear to undertake the initial stages of recognition and repair of specific forms of DNA 
damage. Since there are various kinds of DNA damage, a variety of repair mechanisms are 
essential. Cells integrate DNA repair process with transcription and apoptosis through a 
network known as the DNA damage response (DDR) which is orchestrated by the 
checkpoint proteins.  
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2. DNA repair pathways 
Damages in DNA are repaired by various DNA repair genes belonging to distinct pathways. 
Each pathway is recognized for efficient repair of specific types of DNA damage. To date, 
more than 150 human DNA repair genes have been identified, which can be categorized into 
at least 5 distinct pathways: Base Excision Repair (BER), Nucleotide Excision Repair (NER), 
Mismatch Repair (MMR), Double Strand Break Repair (DSBR), and Transcription Coupled 
Repair (TCR) (Wood et al., 2005). The Base Excision Repair Pathway operates on small 
lesions such as oxidized or reduced bases, fragmented or nonbulky adduct, and adducts 
produced by methylating agents. The Nucleotide Excision repair (NER) pathway repairs 
bulky lesions such as pyramidine dimmers, other products of phytochemical reactions, large 
chemical adducts and DNA crosslinks. For Double Strand Break Repair (DSBR), at least two 
pathways exist: homologous recombination and non homologous end joining. Replication 
errors such as base-base or insert-deletion mismatches caused by the DNA polymerase are 
repaired by Mismatch Repair (MMR) pathway genes. Finally, the suicide enzyme methyl-
guanine-DNA, methyl transferase, is an additional category of DNA repair pathway that 
directly removes the alkylated bases. 
The repair gene products operate in a co-ordinated fashion to form repair pathways that 
control restitution of specific types of DNA damage. Repair pathways are further co-
ordinated with other metabolic processes, such as cell cycle control, to optimize the 
prospects of successful repair. During the cell cycle, checkpoint mechanisms ensure that a 
cell’s DNA is intact before permitting DNA replication and cell division to occur. Failures in 
these checkpoints can lead to an accumulation of damage, which in turn leads to mutations.  
Repair of damaged DNA is of paramount importance and is essential to prevent loss of or in 
correct transmission of genetic information, to prevent genetic damage from propagating 
and accumulating,  to maintain genome integrity and stability of cells, and also to prevent 
mutations The failure of the cell to adequately repair the acquired damage and to undergo 
apoptosis may lead to further errors which can cause developmental abnormalities and 
neoplastic transformation of the cell and finally to carcinogenesis.  
3. Genetic susceptibility to cancer - High and low penetrance DNA  
repair genes  
Genetic susceptibility to cancer result from variations in the genetic code that alter either 
protein expression, function or localization. Susceptibility to cancer is determined by two 
types of genes – high penetrance genes and low penetrance genes. High penetrance genes 
are genes with allelic variants that confer a high degree of risk to the individual. Relatively 
few individuals in the population carry risk –increasing genotypes at these loci. The 
proportion of cancer in the population that may be explained by these genotypes will be 
low. Therefore the population attributable risk also will be low. But high penetrance genes 
have a large magnitude of effects on cancer risk and usually follow a mendelian autosomal 
domiant pattern of inheritance and involve multiple cancer sites that form a cancer 
syndrome. High penetrance genes with an attendant high likelihood of causing cancer, 
account for only a small proportion of cancer cases. In humans, high penetrance DNA repair 
genes that cause family or hereditary cancer syndromes can have substantial impact in 
affected families (eg: BRCA1 and BRCA2 genes in hereditary breast cancer, DNA Mismatch 
Repair (MMR) genes in Hereditary Non Polyposis Colorectal Cancer (HNPCC), p53 in 
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LiFraumeni Syndrome). But these genes affect only a small portion of cancer cases and a 
small percent age of the population.  
Loss of function mutations in a significant number of DNA damage response genes 
predispose to a variety of familial cancers (Spry et al., 2007). There are several examples 
such as mutations in BRCA1 and BRCA2 belonging to homologous recombination pathways 
predispose to breast and ovarian cancer (Bertwistle & Ashworth, 2000). So also, mutations in 
other double strand break repair genes such as ATM predispose to the familial tumorigenic 
condition ataxia telangiectasia (Lavin & Shiloh 1996) and breast cancer (Renwick et al., 
2006). Mutations in NBSI have been reported to predispose to Nijwegen breakage syndrome 
(Matsuura et al., 2004). Somatic mutations in another DSB repair gebe, ATR, correlate with 
sporadic microsatellite (MSI) positive stomach cancer (Menoyo et al., 2001). PALB2 gene, 
which encodes a BRCA2 indicating protein, has also been identified as a breast cancer 
susceptibility gene (Rahman et al., 2007). Mutations in a group of DNA mismatch repair 
(MMR) gene predispose to hereditary non-poplyposis colorectal cancer and other cancers in 
the extra colonic sites in Lynch syndrome (Jacob & Praz, 2002). Biallelic germline mutations 
of the base excision repair gene MUTYH have been identified in patients with autosomal 
recessive form of hereditary multiple colorectal adenoma and carcinoma (Jones et al., 2002). 
Defect in the nucleotide excision repair pathway genes predispose to xeroderma 
pimentosum (XP), Cockayne syndrome (CS) and Trichothiodystrophy (TTD), which are all 
autosomal recessive syndromes (Leibeling et al., 2006). 
In contrast, in the remaining major portion of sporadic cases, genetic variations in the form 
of low to moderate penetrance alleles may predispose individuals to cancer in combination 
with environmental factors and thus affect a large segment of the population. Low 
penetrance genes, also referred to as modifier genes, are genes in which subtle sequence 
variants may be associated with a small to moderate increased relative risk for sporadic 
cancers. 
4. Single Nucleotide Polymorohisms (SNPs) in low penetrance genes  
Genetic variations seen in human genome includes insertion/deletion of one or more 
nucleotides (indels) the copy number variations (CNNs) that can involve DNA sequences of 
a few kilobases up to millions of bases and single nucleotide polymorphisms (SNPs) which 
are the substitution of a single nucleotide along the DNA. With an estimated number of 
more than 10 million to be present in the human genome, SNPs are the most common form 
of genetic variation (Miller et al., 2005). 
Variations in several classes of low penetrance genes known as Single nucleotide 
polymorphism (SNPs) are very common in the population. SNPs are DNA sequence 
variations that occur when a single nucleotide (A, T, C, or G) in the genome sequence is 
altered. For a variation to be considered as SNP, it must be present in at least 1% of the 
population. SNPs are relatively common in the population and as such may be associated 
with a much higher attributable risk in the population as a whole than the rare high 
penetrance genes. Therefore, variants in low penetrance genes could explain a greater 
proportion of sporadic cancers than the high penetrance genes. SNPs acting together with 
environmental factors are well documented candidates for cancer susceptibility. Even 
though, SNPs in these low penetrance genes have only small effect when considered singly, 
they may produce a high risk profile when acting together with other shared genetic 
variants and environmental factors (Gary et al., 1999). On the basis of biological plausibility, 
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SNPs in low penetrance genes whose protein products would affect a pathway involved in 
carcinogenesis have been documented as cancer predisposition or susceptibility risk factors. 
Low penetrance candidates are found in a wide variety of pathways ranging from 
metabolism and detoxification or environmental carcinogens to DNA damage repair.  
The recognition that carcinogens can also be mutagens that change the DNA sequence gave 
impetus to the relevance of DNA damage and repair to carcinogenesis. All the effects of 
exogenous factors and endogenous factors on tumor production could be accounted for by 
the DNA damage that they cause and by the errors introduced into DNA during the cell’s 
efforts to repair this damage. According to the mutator phenotype hypothesis, cancer 
phenotypes result from mutations in genes that maintain genetic stability in normal cells. 
Mutations in genetic stability genes can cause mutations in other genes that govern genetic 
stability, initiating a cascade of mutations throughout the genome. So, the prompt response 
of the cells to repair genetic injury and its ability to maintain genomic stability by means of a 
variety of DNA repair mechanisms are therefore essential in preventing tumor initiation and 
progression. 
Genetic variants or mutations in high penetrance genes are disease causing whereas genetic 
variations in low penetrance genes are insufficient to cause cancer, but may influence cancer 
risk. So genetic variants in low penetrance genes are disease risk associated. Individual low 
penetrance risk alleles are insufficient to cause cancer, but influence cancer risk. Low 
penetrance genes, with an attendant increased risk of causing cancer, albeit, less likely than 
high penetrance genes (Ponder, 2001; Shields & Harris, 2000) predispose individuals to 
cancer upon interacting with environmental factors. 
5. SNPs in DNA damage repair genes 
DNA repair mechanisms are controlled by specific set of genes encoding the enzymes that 
catalyze cellular response to DNA damage. It is well documented that loss of repair 
function, or alteration of the control of repair process, can have very serious consequences 
for cells and individuals and can lead to development of cancer. Several genes involved in 
DNA repair pathways are considered to be low penetrance genes. A link between failure of 
DNA repair and carcinogens was suggested when individuals with chromosome breakage 
syndrome such as Xeroderma Pigmentosum, Fanconi Anemia, Bloom Syndrome, Ataxia 
telangiectasia who have inherited genetic defects in certain DNA repair systems were 
recognized to be at an increased susceptibility to development of certain cancers. 
Because DNA damage is associated with cancer development, it was hypothesized that 
genes involved in DNA damage repair may influence cancer susceptibility. Polymorphisms 
in DNA repair genes may be associated with differences in the DRC of DNA damage and 
may influence an individual’s risk for cancer, because the variant genotype in those 
polymorphisms might destroy or alter repair function. A large number of SNPs have been 
determined among individuals in DNA repair genes. It has been documented that genetic 
variations in DNA damage repair genes could result in variations in efficacy and accuracy of 
DNA repair enzymes and could have effect on the sensitivity of the organism to 
environmental genotoxins. 
Genetic variation in DNA repair genes in each of the five DNA repair pathways has been 
implicated in cancer susceptibility (Berwick & Vineis 2000; Goode et al., 2002). Genetic 
variations such as SNPs in DNA repair genes are associated with reduced function of their 
encoded proteins, rather than absence of function and may alter an individual’s capability to 
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repair damaged DNA. This may result in gene product (protein) not being formed, or that 
the protein is less active, or that it is formed in an uncontrolled fashion, may be at the wrong 
time, or in the wrong amount. Some minor genetic alterations may not affect protein 
activity, or interactions, whereas others may significantly disrupt cellular function. It is 
also possible that since certain proteins work in a number of different processes or 
complexes, the loss or impairment of one type of protein can affect several different 
functions of the cell and organism. Deficiency or impairment in DNA repair genes which 
results in alteration of the key gene expression may have an influence on DNA repairs 
functions and could lead to altered cancer risk. The importance of these mechanisms in 
cancer prevention is evident from the increased cancer risk associated with disruption of 
these pathways (Digweed, 2003). So studies on DNA repair as a susceptibility factor for 
cancer are increasing exponentially. Majority of cancer susceptibility studies have focused 
on the identification of low-penetrance disease susceptibility alleles applying candidate 
gene pathway studies and genome wide association studies. Genetic association studies 
and genome wide association scans have identified a number of polymorphisms in 
several low penetrance genes and their role in etiology of several cancers, through risk 
modification (Tomlinson et al., 2008). 
DNA double strand breaks (DSBs) which can result from a variety of factors including 
ionizing radiation, free radicals, replication errors, telomere dysfunction are one of the most 
severe types of DNA damage (Khanna & Jackson, 2001). Unpaired or misrepaired DSBs can 
lead to cell death, genomic instability and oncogenic transformation (Jeggo & Jackson, 2001). 
Homologous recombination (HR) and nonhomologous enjoining (NHEJ) are the two major 
DSB repair pathways in mammalian cells. Reports are available suggesting that several 
Single Nucleotide Polymorphisms in the NHEJ genes may be relevant to modify the risk of 
multiple myloma (Roddam et al., 2002), glioma (Liu et al., 2008) and, breast cancer (Garcia-
Closas et al., 2006). Another study by (Tseng et al., 2009), showed significant association 
between the XRCC4 and LIGH genotypes with non-small cell lung cancer (NSCLC) risk in 
an analysis of individual polymorphism associations, and the risk of NSCLC increased 
further in a combined analysis of multiple polymorphisms. 
6. XRCC3 
The X-ray repair cross-complementing group 3 (XRCC3), the DNA repair gene which codes 
for a protein participating in homologous recombination repair (HRR) of double strand 
breaks (DSB), has been of considerable interest as a candidate gene for cancer susceptibility. 
The variant allele of the Thr241Met had been reported to have relatively high DNA adduct 
levels in lymphocyte DNA and hence with relatively low DNA repair capacity (Matullo et 
al., 2001). Several molecular epidemiologic studies have been performed to evaluate the role 
of XRCC3 polymorphisms such as XRCC3 4541 A>G, XRCC3 17893 A>G, XRCC3 Thr 241 
Met on various neoplasms, such as cancer of breast, lung, bladder, colorectal, head and 
neck, skin etc (Han et al., 2004; Shen et al., 2004; Ritchey et al., 2005; Jin et al., 2005; Matullo 
et al.,2005; Garcia-Closas et al., 2006; Zienoldding et al., 2006; Yi et al., 2006). But rather than 
conclusive, the results from these studies remain fairly conflicting. Ahmd Aizat (2011) 
reported lack of association of XRCC3 Thr 241 Met with sporadic colorectal cancer 
susceptibility in Malaysian population. (Han et al., 2006) performed a meta –analysis on 
XRCC3 polymorphism and cancer risk involving 48 case-control studies including 24,975 
cancer patients and 34,209 controls. From the analysis results, (Han et al., 2006) reported that 
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individuals carrying the XRCC3 Met/Met genotype showed a. small cancer risk under a 
recessive genetic model. Specifically, the XRCC3 Met/Met genotype showed significantly 
increased risk of breast cancer, but not significant risk of cancer for head and neck, bladder, 
and non-melanoma skin cancer. This meta analysis results support that the XRCC3 might 
represent a low penetrance susceptible gene especially for cancer of breast, bladder, head 
and neck, and non-melanoma skin cancer.  
7. XRCC1 
The X-Ray Cross Complementing group I XRCC1 gene belongs to The Base Excision 
Repair IBER) pathway. The XRCC1 gene product plays an important role in the BER 
pathway by acting as a scolfold for the other DNA repair proteins, such as DNA 
polymerase B (Kubota et al., 1996), and DNA ligase III (Caldecott, 2003). Few common 
single nucleotide polymoprhisms of the XRCC1 gene have been identified at codon 194 
(G>T substitution at position 26304, exon 6, Arg to Trp), codon 280 (G>A substitution at 
position 27466, exon 9, Arg to His) and 399 (G>A substitution at position 28152, exon 10, 
Arg to Gln). The individuals carrying XRCC1 399 variants have been shown to have 
higher levels of DNA adduct (Lunn et al., 2000) and to be at greater risk for tobacco 
related DNA damage (Lei et al., 2002). Few studies reported XRCC1 399AA genotype to 
be significantly associated with lung cancer risk in Caucasian population (Divine et al., 
2001; Zhou et al., 2003), Korean population (Park et al., 2002), and Indian population 
(Sreeja et al., 2008). 
8. XPD (ERCC2)  
Xeroderma Pigmentosum group D (XPD) also known as ERCC2 (Excision Repair Cross 
Completing group 2) gene encodes a helicase, a major DNA repair protein, which is 
involved in transcription-coupled NER and in the removal of a variety of structurally 
unrelatedas DNA lesions (Lehmann, 2001) including those induced by tobacco carcinogens 
(Leadon & Cooper, 1993), (Tang et al., 2002). The normal functioning XPD protein plays an 
essential role in NER and participates in the unwinding of DNA at the site of deleterious 
DNA lesions (Hoeijmakers et al., 1996). Several studies have reported association between 
A751C variant of XPD and increased risk of lung cancer (Hou et al., 2002; Spitz et al 2003; 
Ramachandran et al., 2006). Hou et al., 2003 reported a marginally increased risk for those 
carrying heterozygous A>C transversions, compared to those with wildtype homozygous, 
indicating that heterozygosity also carry the risk. In a Northeastern Chinese population, 
XPD 751 AC heterozygous genotype carriers were at 2.7 fold higher risk of lung cancer than 
carrier of AA genotype (Yin et al., 2006). A significant association of XPD variants in 
modulating NSCLC risk was reported by Zienolddiny et al (2006) in Norwegian lung cancer 
population. So also, in an Indian population, Sreeja et al., (2008) also reported significant 
association of XPD heterozygous variants in modulating Non small cell lung cancer risk. 
SNPs in genes involved in nucleotide excision repair (ERCC1, XPD, XPC, XPA, XPF and 
XPG) and mismatch repair genes (MLH1 and MSH2) in 577 colorectal cancer cases and 307 
case-affected sibling controls were examined by Joshi et al., (2009). Their results showed that 
consumption of red meat, heavily brown on the outside or inside, increased colorectal 
cancer risk only among subjects with XPD codon 751 Lys/Lys or XPD codon 312 Asp/Asp 
genotypes.  
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9. P53 
The P53 gene plays a critical role in cell cycle control, the initiation of apoptosis, and 
maintenance of genomic stability and in DNA repair (Levine, 1997). TP53 is highly 
polymorphic in coding and non coding regions and some of these polymorphisms have 
been shown to increase cancer susceptibility and modify cancer phenotypes in TP53 
mutation carriers (Whibley et al., 2009). Over 80 TP53 polymorphisms have been identified 
and validated in human populations. (IARC TP53 Database, R13). Nearly 90% are located in 
introns, outside splice sites, or in non coding exons. Among the P53 polymorphism, the 
codon 72 polymorphism (Arg72 Pro) in exon 4 of TP53 is the most extensively studied, both 
in experimental and population studies. Codon 72 is located within a proline rich region and 
Arg72 has been reported to be more effective in inducing apoptosis than Pro72. The 
Arg/Pro polymorphism at codon 72 of the P53 gene alters the ability of the P53 protein to 
induce apoptosis, influences the behaviour of mutant P53, decreases the DNA repair 
capacity and has been linked to with an increased risk of cancer, especially lung cancer. 
Several studies have examined the associations between P53 codon 72 (Arg72Pro) 
polymorphism and risk of different cancers, but with in consistent results. Few studies 
reported higher risk for lung cancer in individuals with the Arg/Pro or Pro/Pro genotype 
and especially Pro/Pro genotype with smoking induced lung cancer (Weston et al., 1992; Jin 
et al., 1995 ; Fan et al., 2000; Zhou et al., 2001). In a Chilean population, Fan et al., (2000) 
investigated the influence of polymorphic genotype TP53 on lung cancer susceptibility and 
the Pro/Pro genotype of TP53 was found to contribute significantly to lung cancer 
susceptibility risk [ OR 3.88 (95% CI 1.16 – 13.39) ]. The study by Alexandrov et al (2002) 
were consistent with the hypothesis that Benzo(a)pyrene (Polycyclic aromatic hydrocarbon, 
PAH) induce G : C to T : A transverse mutations in the hotspot codons of TP53 and are 
hence involved in the malignant transformation of the lung tissue of smokers. In an Indian 
case – control study involving 211 lung cancer cases and 211 controls, Sreeja et al (2007) 
reported an OR of 2.5 (95% CI 1.470 4.302 , p= 0.001) for the TP53 Pro/Pro variant genotype 
for lung cancer susceptibility and the risk tended to be higher for women  
[ OR =2.4 , p=0.003 ] . Recently, Ahmd Aizat (2011) reported a significant association of 
Pro/Pro homozygous variant of p53 with sporadic colorectal cancer susceptibility  
(OR = 1.886, CI: 1,046 – 3.399 , p= 0,035) and suggested that p53 Pro72Pro genotype carriers 
might be having a higher risk for Colorectal cancer susceptibility in Malaysian population  
(personal communication, unpublished data) However, meta-analysis on the risk 
association of TP53 Arg72Pro polymorphism with lung cancer (Matakidou et al., 2003) and 
breast cancer (Schmidt et al., 2007) do not support a significant role for this polymorphism 
in susceptibility. 
10. MMR genes 
In the maintenance of genomic stability, the DNA mismatch repair (MMR) systems 
comprising of various MMR genes play a key role. MMR genes mediate DNA repair 
through removal of mismatched nucleotide pairs and insertion/ deletion heterologies 
generated during DNA replication. Germ line mutations as well as hypermethylation in 
MMR genes have been reported in familial/hereditary forms of colorectal cancer. So, it was 
hypothesized that common variants in relevant genes encoding DNA MMR enzymes might 
impact the risk of sporadic form of CRC and studies have been carried out to explore this 
possibility. Even though the functional relevance of majority of polymorphisms in the genes 
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involved in MMR is not known, recent studies suggest an influence of SNPs or biochemical 
interaction between components of the MMR pathways or on epigenetic mediated 
functional regulation (Chen et al., 2007).  
Several common polymorphisms in DNA repair genes representing different repair 
pathways have been reported. Many studies have been carried out to elucidate the 
association between DNA repair gene polymorphisms and cancer susceptibility. But studies 
have shown inconsistent associations. The impact of many these polymorphisms on repair 
phenotype and cancer susceptibility remain uncertain (Berwick & Vineis, 2000; Au et al., 
2004). In a study on 5 DNA repair genes (XRCC1 Arg194Trp and Arg399gln, PARP 
Val762Ala and Lys940Arg, XPD Asp312Asn and Lys751Gln, OGG1 Ser326Cys MGMT 
Leu84Phe) in Singaporean Chinese population, Stern et al., (2007) provided support to the 
hypothesis that selected variants in DNA repair genes may contribute to colorectal cancer 
risk and may modify the effects of relevant life style risk factors that have been 
inconsistently associated with the disease. This study which reported the overall effects of 
PARP on colorectal cancer risk and XRCC1 SNPs as modifiers of the effects of smoking and 
alcohol on colorectal cancer risk, also highlighted the role of the base excision repair 
pathway in colorectal carcinogenesis. Vinies et al (2009) conducted meta-analyses of 241 
associations between variants in DNA repair genes and cancer and had found sparse 
association signals with strong epidemiological credibility. Using 1087 datasets and publicly 
available data from genome wide association platforms, meta-analysis using dominant and 
recessive models were performed on 241 associations between individual variants and 
specific cancer types that had been tested in two or more independent studies. Thirty one 
nominally statistically significant (P<0.05 without adjustment for multiple comparisons) 
associations were recorded for 16 genes in dominant and/or recessive model analyses 
(BRCA2, CCND1, ERCC1, ERCC2, ERCC4, ERCC5, MGMT, NBN, PARP1, POL1, TP53, 
XPA, XRCC1, XRCC2, XRCC3 and XRCC4). XRCC1, XRCC2, TP53, and ERCC2 variants 
were each nominally associated with several types of cancer. Three associations were 
graded as having “strong” credibility, another four had “modest” credibility and 24 had 
“weak” credibility based on Vinies criteria. Requiring more stringent P values to account for 
multiplicity of comparisons, only the associations of ERCC2 codon 751 (recessive model) 
and of XRCC1-77 T>C (dominant-model) with lung cancer had P≤ 0.0001 and retained P≤ 
0.001 even when the first published studies on the respective associations were excluded. 
The analyses suggested that the vast majority of postulated associations between DNA 
repair alleles and cancer risk have not been replicated sufficiently to give them strong 
credibility. This meta-analysis implies that larger scale studies would be necessary to 
establish specific associations of genetic variants in DNA repair and cancer and that the 
added risk conferred by single variants in DNA repair genes may be small. In another recent 
meta analysis, (Kiyohara et al.) found XPA G23A, OGG1 Ser326Cys and XPD Lys751Gln 
polymorphisms were associated with lung cancer risk . 
11. Limitations and future prospectives 
In SNP association studies, the most important critical point is associated with often too 
small size of cohort of cases and controls, resulting in a low statistical power and false, by 
chance, positive or negative outcomes. Another important aspect concerns inclusion of 
different ethnic groups. Different results may be expected due to intrinsic difference in 
genetic background among Caucasians, Asians, Afro Americans and other ethnic groups. 
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There is wide population variability in repair capability phenotype on account of the 
variation in the polymorphic allele frequencies of DNA repair genes between different 
ethnic groups. Even through majority of SNPs are common to at least three historic human 
populations (Caucasians, Africans, Asians), some SNPs are specific to different ethnicities. 
These differences among human populations has highlighted the need to consider ethnic 
genetic differences while conducting genetic association studies evaluating disease risk, 
treatment response and outcome studies. This could also be accounting for a several fold 
variation in cancer risk and significant heterogeneity across all included studies. So 
susceptibility factor in one population may not be a factor in another population. Thus, 
different study designs, differences in the prevalence of genetic polymorphisms and linkage 
disequilibrium in different ethnic populations are possible explanations for the varying 
results obtained in different studies across the world. Effect modification by environmental 
or other genetic risk factors that differ between study populations are also alternative 
causes. This warrants the need to undertake large studies on homogeneous populations to 
avoid such influences. .  
It is hoped that in future, advances in genotyping utilizing high throughput genotyping 
methods could facilitate the analysis of multiple polymorphisms within DNA repair genes 
and also the analysis of multiple genes within DNA repair pathways.  Data generated from 
multiple polymorphisms within a gene can be combined to create haplotypes , the set of 
multiple alleles on a single chromosome. Because of higher heterozygosity and tighter 
linkage disequilibrium within disease causing mutations, haplotype analysis can increase 
the power to detect disease associations. Haplotype analysis also allows for the possibility of 
an ungenotyped functional variant to be in linkage disequilibrium with the genotyped 
polymorphisms. Investigations on gene-gene interactions or pathway analysis also would 
provide more comprehensive insight into the role of low penetrance genetic variants of 
DNA repair genes in cancer susceptibility.  The identification of common, moderate or low 
penetrance genes for cancer will potentially be of great benefit , because it allows screening 
to be targeted to those at greatest risk which in turn will help in implementing cancer 
prevention strategies. 
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